Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity
1 other identifier
interventional
120
1 country
1
Brief Summary
Visual acuity (VA) is the most common measure of visual function globally. In clinical settings and during screening events, VA is an important measure to quantify changes in vision over time. Additionally, in the context of epidemiological studies and population-based surveys, VA is a critical measure to determine the presence and degree of vision impairment and to report on the indicators of effective eye care service coverage (i.e. refractive error and cataract surgery), that are currently considered by World Health Organization (WHO) for monitoring progress towards the Universal Health Coverage. There are numerous applications for assessing VA; however, the number of validated applications is limited. In this study, the investigators aim to evaluate the external validity, intra- and inter-observer reliability, and feasibility of two applications ("Easy Vision" and "Peek Acuity") for testing the visual acuity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedStudy Start
First participant enrolled
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2022
CompletedJuly 27, 2022
April 1, 2021
6 months
April 25, 2021
July 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Distance visual acuity assessment with Easy Vision versus Peek Acuity versus conventional distance visual acuity chart
To assess the agreement between two smartphone-based evaluation of distance visual acuity (LogMAR unit) with Easy Vision and Peek Acuity and a conventional distance visual acuity chart (Tumbling E optotype)
Through study completion [an average of 6 months]
Near visual acuity assessment with Easy Vision versus Peek Acuity versus conventional near visual acuity chart
To assess the agreement between two smartphone-based evaluation of near visual acuity (LogMAR unit) with Easy Vision and Peek Acuity and a conventional near visual acuity chart (Handheld chart: Tumbling E Near Point Vision Chart)
Through study completion [an average of 6 months]
Study Arms (4)
Visual acuity assessment using "Vision Screening module" of "Easy Vision" application
EXPERIMENTALVisual acuity assessment using "Test Yourself module" of "Easy Vision" application
EXPERIMENTALVisual acuity assessment using "Peek Acuity" application
EXPERIMENTALVisual acuity assessment using the conventional methods
OTHERInterventions
The presenting visual acuity will be assessed using the Vision Screening module of the "Easy Vision" application.
The presenting visual acuity will be assessed using the Test Yourself module of the "Easy Vision" application.
The presenting visual acuity will be assessed using the "Peek Acuity" application.
The presenting visual acuity will be assessed using the conventional methods \["Chart: Tumbling E optotype" for assessing distance visual acuity and "Handheld chart: Tumbling E Near Point Vision Chart" for assessing near visual acuity\]
Eligibility Criteria
You may qualify if:
- Age ≥10 years old
You may not qualify if:
- Subjects who are not able to respond to the examiner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
Tehran, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Ophthalmic Research Center
Study Record Dates
First Submitted
April 25, 2021
First Posted
June 23, 2021
Study Start
June 23, 2021
Primary Completion
December 23, 2021
Study Completion
January 30, 2022
Last Updated
July 27, 2022
Record last verified: 2021-04